Patents by Inventor Cristina Rondinone

Cristina Rondinone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
    Publication number: 20190092877
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 28, 2019
    Inventors: Anthony CELESTE, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Anti-PCSK9-GLP-1 fusions and methods for use
    Patent number: 10077319
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: September 18, 2018
    Assignees: MedImmune, LLC, MedImmune Limited
    Inventors: Anthony Celeste, Matthieu Chodorge, Andrew Buchanan, Cristina Rondinone, Joseph Grimsby, Peter Ravn, Jonathan Seaman, David Fairman
  • ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
    Publication number: 20160369010
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: February 20, 2015
    Publication date: December 22, 2016
    Inventors: Anthony Celeste, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
    Publication number: 20070135351
    Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
    Type: Application
    Filed: December 1, 2006
    Publication date: June 14, 2007
    Inventors: Karin Conde-Knape, Waleed Danho, George Ehrlich, Nader Fotouhi, David Fry, Wajiha Khan, Anish Konkar, Cristina Rondinone, Joseph Swistok, Rebecca Taub, Jefferson Tilley
  • Methods of identifying kinases and uses thereof
    Publication number: 20050037987
    Abstract: The subject invention relates to a method of identifying kinases as targets which may be utilized in the development of therapies for metabolic disorders. Additionally, the present invention relates to a method of screening potential therapeutic agents for the ability to prevent IRS-1 degradation and enhance insulin signaling.
    Type: Application
    Filed: April 22, 2004
    Publication date: February 17, 2005
    Inventors: Cristina Rondinone, Regina Reilly, Jill Clampit, Deanna Haasch